News Focus
News Focus
icon url

dennisdave

02/03/24 3:27 PM

#669821 RE: exwannabe #669816

You are absolutely right. The claim here that all cancer treatments, FDA-approved or not, are failed drugs because its not DCVAX is completely insane.
Blind fanatics
icon url

biosectinvestor

02/03/24 3:35 PM

#669822 RE: exwannabe #669816

That may be but if DCVax-L had those kinds of sales I think it is a virtual certainty that YOU and every short here would label it a “bust”. Meanwhile the long you replied to said the opposite, that Gilead paid $21B for it.

Shorts play all sides of every argument to always argue, maximally, that longs are “delusional”, that other drugs are better, regardless of the details, and that DCVax-L is a bust, again, regardless of details.

So yeah, if DCVax-L generated those levels of sales, I am pretty certain shorts would be on here day and night saying, “it’s a bust”!!! What else would they or could they do?
icon url

CrashOverride

02/03/24 3:39 PM

#669824 RE: exwannabe #669816

DCVax has not failed a trial while targets all antigens and neoantigens. It makes ADCs like Trodelvy an inferior technology as flipper astutely illuminated.